Depersonalization disorder

被引:17
作者
Reutens, Sharon [1 ,2 ]
Nielsen, Olav [3 ]
Sachdev, Perminder [4 ]
机构
[1] Bankstown Hosp, Dept Old Age Psychiat, Sydney, NSW, Australia
[2] Justice Hlth, Sydney, NSW, Australia
[3] St Vincents Hosp, Clin Res Unit Anxiety & Depress, Sydney, NSW 2010, Australia
[4] Prince Wales Hosp, Inst Neuropsychiat, Sydney, NSW, Australia
关键词
depersonalization; depersonalization disorder; dissociation; BORDERLINE PERSONALITY-DISORDER; POSTTRAUMATIC-STRESS-DISORDER; PITUITARY-ADRENAL AXIS; ILLICIT DRUG-USE; EMOTIONAL MEMORY; FEELING UNREAL; LAMOTRIGINE; TRIAL; FLUOXETINE; NALOXONE;
D O I
10.1097/YCO.0b013e3283387ab4
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Purpose of review There is increasing interest in depersonalization disorder, in part because of the increased community awareness of the condition via the Internet. The disorder may be more prevalent than schizophrenia but is often misdiagnosed; hence, an update is timely. Recent findings Recent research has included characterization of the nosology and phenomenology of the disorder, whereas emerging evidence demonstrates a neurophysiological dampening down in addition to psychological dampening in the face of emotional stimulation. Summary Greater understanding of the clinical characteristics of this disorder will improve the reliability of diagnosis and aid the development of neurobiological and psychological models for empirical testing. Although response to current treatments has been disappointing, recent research has identified the basis for the development of new pharmacological and psychological treatments
引用
收藏
页码:278 / 283
页数:6
相关论文
共 65 条
[1]   Ketamine alters neural processing of facial emotion recognition in healthy men: an fMRI study [J].
Abel, KM ;
Allin, MPG ;
Kucharska-Pietura, K ;
David, A ;
Andrew, C ;
Williams, S ;
Brammer, MJ ;
Phillips, ML .
NEUROREPORT, 2003, 14 (03) :387-391
[2]   Attenuation of the neuropsychiatric effects of ketamine with lamotrigine -: Support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists [J].
Anand, A ;
Charney, DS ;
Oren, DA ;
Berman, RM ;
Hu, XS ;
Cappiello, A ;
Krystal, JH .
ARCHIVES OF GENERAL PSYCHIATRY, 2000, 57 (03) :270-276
[3]  
[Anonymous], 2000, DIAGN STAT MAN MENT, DOI DOI 10.1176/APPI.BOOKS.9780890425787
[4]   Depersonalisation disorder: clinical features of 204 cases [J].
Baker, D ;
Hunter, E ;
Lawrence, E ;
Medford, N ;
Patel, M ;
Senior, C ;
Sierra, M ;
Lambert, MV ;
Phillips, ML ;
David, AS .
BRITISH JOURNAL OF PSYCHIATRY, 2003, 182 :428-433
[5]   Illness perceptions in depersonalization disorder: Testing an illness attribution model [J].
Baker, Dawn ;
Earle, Michelle ;
Medford, Nicholas ;
Sierra, Mauricio ;
Towell, Anthony ;
David, Anthony .
CLINICAL PSYCHOLOGY & PSYCHOTHERAPY, 2007, 14 (02) :105-116
[6]   DEVELOPMENT, RELIABILITY, AND VALIDITY OF A DISSOCIATION SCALE [J].
BERNSTEIN, EM ;
PUTNAM, FW .
JOURNAL OF NERVOUS AND MENTAL DISEASE, 1986, 174 (12) :727-735
[7]   Naltrexone in the treatment of dissociative symptoms in patients with borderline personality disorder:: An open-label trial [J].
Bohus, MJ ;
Landwehrmeyer, GB ;
Stiglmayr, CE ;
Limberger, MF ;
Böhme, R ;
Schmahl, CG .
JOURNAL OF CLINICAL PSYCHIATRY, 1999, 60 (09) :598-603
[8]   Migraine and depersonalization disorder [J].
Cahill, CM ;
Murphy, KC .
CEPHALALGIA, 2004, 24 (08) :686-687
[9]  
CATTELL JP, 1974, AM HDB PSYCHIAT, P767
[10]   Medication-associated depersonalization symptoms: Report of transient depersonalization symptoms induced by minocycline [J].
Cohen, PR .
SOUTHERN MEDICAL JOURNAL, 2004, 97 (01) :70-73